{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:18:52Z","timestamp":1791296332535,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1093\/brain\/awl024","type":"journal-article","created":{"date-parts":[[2006,2,9]],"date-time":"2006-02-09T01:27:18Z","timestamp":1139448438000},"page":"953-962","source":"Crossref","is-referenced-by-count":257,"title":["Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage"],"prefix":"10.1093","volume":"129","author":[{"given":"Kazuaki","family":"Kanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoko","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Ogawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setsu","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Bostock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,2,8]]},"reference":[{"key":"key\n\t\t\t\t20171011181925_B1","doi-asserted-by":"crossref","unstructured":"Anderson AJ, Harvey AL. Effect of the potassium channel blocking dendrotoxins on acetylcholine release and motor nerve terminal activity. Br J Pharmacol1988; 93: 215\u201321.","DOI":"10.1111\/j.1476-5381.1988.tb11424.x"},{"key":"key\n\t\t\t\t20171011181925_B2","doi-asserted-by":"crossref","unstructured":"Baker MD. Axonal flip-flops and oscillators. Trends Neurosci2000; 23: 514\u20139.","DOI":"10.1016\/S0166-2236(00)01645-3"},{"key":"key\n\t\t\t\t20171011181925_B3","doi-asserted-by":"crossref","unstructured":"Beltran-Parrazal L, Charles A. Riluzole inhibits spontaneous Ca2+ signalling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels. Br J Pharmacol2003; 140: 881\u20138.","DOI":"10.1038\/sj.bjp.0705491"},{"key":"key\n\t\t\t\t20171011181925_B4","doi-asserted-by":"crossref","unstructured":"Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol1997; 498: 277\u201394.","DOI":"10.1113\/jphysiol.1997.sp021857"},{"key":"key\n\t\t\t\t20171011181925_B5","doi-asserted-by":"crossref","unstructured":"Bostock H, Baker M, Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol1991; 441: 537\u201357.","DOI":"10.1113\/jphysiol.1991.sp018766"},{"key":"key\n\t\t\t\t20171011181925_B6","doi-asserted-by":"crossref","unstructured":"Bostock H, Sharief K, Reid G, Murray NMF. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain1995; 118: 217\u201325.","DOI":"10.1093\/brain\/118.1.217"},{"key":"key\n\t\t\t\t20171011181925_B7","doi-asserted-by":"crossref","unstructured":"Bostock H, Cikurel K, Burke D. Threshhold tracking techniques in the study of human peripheral nerve. Muscle Nerve1998; 21: 137\u201358.","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C"},{"key":"key\n\t\t\t\t20171011181925_B8","doi-asserted-by":"crossref","unstructured":"Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol2001; 112: 1575\u201385.","DOI":"10.1016\/S1388-2457(01)00595-8"},{"key":"key\n\t\t\t\t20171011181925_B9","doi-asserted-by":"crossref","unstructured":"de Carvalho M, Swash M. Fasciculation potentials: a study of amyotrophic lateral sclerosis and other neurogenic disorders. Muscle Nerve1998; 21: 336\u201344.","DOI":"10.1002\/(SICI)1097-4598(199803)21:3<336::AID-MUS7>3.0.CO;2-B"},{"key":"key\n\t\t\t\t20171011181925_B10","doi-asserted-by":"crossref","unstructured":"Cikurel K, Murray NMF, Bostock H. The use of threshold electrotonus in motor neurone disease. Electroencephalogr Clin Neurophysiol1997; 103: 168.","DOI":"10.1016\/S0013-4694(97)88783-8"},{"key":"key\n\t\t\t\t20171011181925_B11","doi-asserted-by":"crossref","unstructured":"Dadson PD, Billups B, Rusznak Z, Szucus G, Baker MC, Forsythe ID. Presynaptic rat Kv1.2 channels suppress synaptic terminal hyperexcitability following action potential invasion. J Physiol2003; 550: 27\u201333.","DOI":"10.1113\/jphysiol.2003.046250"},{"key":"key\n\t\t\t\t20171011181925_B12","doi-asserted-by":"crossref","unstructured":"Devaux JJ, Kleopa KA, Cooper EC, Scherer SS. KCNQ2 is a nodal K+ channel. J Neurosci2004; 24: 1236\u201344.","DOI":"10.1523\/JNEUROSCI.4512-03.2004"},{"key":"key\n\t\t\t\t20171011181925_B13","doi-asserted-by":"crossref","unstructured":"Eisen A, Weber M. Treatment of amyotrophic lateral sclerosis. Drugs Aging1999; 14: 173\u201396.","DOI":"10.2165\/00002512-199914030-00003"},{"key":"key\n\t\t\t\t20171011181925_B14","doi-asserted-by":"crossref","unstructured":"Grunnet M, Jespersen T, Angelo K, Frokjaer-Jensen C, Klaerke DA, Olesen SP, et al. Pharmacological modulation of SK3 channels. Neuropharmacology2001; 40: 879\u201387.","DOI":"10.1016\/S0028-3908(01)00028-4"},{"key":"key\n\t\t\t\t20171011181925_B15","doi-asserted-by":"crossref","unstructured":"Gurney ME. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci1997; 152 (Suppl. 1): S67\u2013S73.","DOI":"10.1016\/S0022-510X(97)00247-5"},{"key":"key\n\t\t\t\t20171011181925_B16","doi-asserted-by":"crossref","unstructured":"Hales JP, Lin CS-Y, Bostock H. Variations in excitability of single human motor axons, related to stochastic properties of nodal sodium currents. J Physiol2004; 559: 953\u201364.","DOI":"10.1113\/jphysiol.2004.068726"},{"key":"key\n\t\t\t\t20171011181925_B17","doi-asserted-by":"crossref","unstructured":"Hjorth RJ, Walsh JC, Willison RG. The distribution and frequency of spontaneous fasciculations in motor neurone disease. J Neurol Sci1973; 18: 469\u201374.","DOI":"10.1016\/0022-510X(73)90140-8"},{"key":"key\n\t\t\t\t20171011181925_B18","doi-asserted-by":"crossref","unstructured":"Horn S, Quasthoff S, Grafe P, Bostock H, Renner R, Schrank B. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve1996; 19: 1268\u201375.","DOI":"10.1002\/mus.880191002"},{"key":"key\n\t\t\t\t20171011181925_B19","doi-asserted-by":"crossref","unstructured":"Jiang YM, Yamamoto M, Kobayashi Y, Yoshihira T, Liang Y, Terao S, et al. Gene expression profile of spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol2005; 57: 236\u201351.","DOI":"10.1002\/ana.20379"},{"key":"key\n\t\t\t\t20171011181925_B20","doi-asserted-by":"crossref","unstructured":"Jonas P, Koh DS, Kampe K, Hermsteiner M, Vogel W. ATP-sensitive and Ca-activated K channels in vertebrate axons: novel links between metabolism and excitability. Pflugers Arch1991; 418: 68\u201373.","DOI":"10.1007\/BF00370453"},{"key":"key\n\t\t\t\t20171011181925_B21","doi-asserted-by":"crossref","unstructured":"Kanai K, Kuwabara S, Arai K, Sung JY, Ogawara K, Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain2003; 126: 965\u201373.","DOI":"10.1093\/brain\/awg073"},{"key":"key\n\t\t\t\t20171011181925_B22","doi-asserted-by":"crossref","unstructured":"Kiernan MC, Bostock H. Effects of membrane polarization and ischemia on the excitability properties of human motor axons. Brain2000; 123: 2542\u201351.","DOI":"10.1093\/brain\/123.12.2542"},{"key":"key\n\t\t\t\t20171011181925_B23","unstructured":"Kiernan MC, Burke D. Threshold electrotonus in the assessment of motor neuron disease. In: Eisen A, editor. Clinical Neurophysiology of Motor Neuron Diseases. Handbook of Clinical Neurophysiology. Amsterdam: Elsevier, 2005. p. 399\u2013409."},{"key":"key\n\t\t\t\t20171011181925_B24","doi-asserted-by":"crossref","unstructured":"Kiernan MC, Burke D, Andersen K, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve2000; 23: 399\u2013409.","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G"},{"key":"key\n\t\t\t\t20171011181925_B25","doi-asserted-by":"crossref","unstructured":"Kiernan MC, Cikurel K, Bostock H. Effects of temperature on the excitability properties of human motor axons. Brain2001; 124: 816\u201325.","DOI":"10.1093\/brain\/124.4.816"},{"key":"key\n\t\t\t\t20171011181925_B26","doi-asserted-by":"crossref","unstructured":"Kiernan MC, Hart IK, Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry2001; 70: 56\u201364.","DOI":"10.1136\/jnnp.70.1.56"},{"key":"key\n\t\t\t\t20171011181925_B27","doi-asserted-by":"crossref","unstructured":"Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain2002; 125: 664\u201375.","DOI":"10.1093\/brain\/awf041"},{"key":"key\n\t\t\t\t20171011181925_B28","doi-asserted-by":"crossref","unstructured":"Kiernan MC, Isbister GK, Lin CS, Burke D, Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol2005; 57: 339\u201348.","DOI":"10.1002\/ana.20395"},{"key":"key\n\t\t\t\t20171011181925_B29","doi-asserted-by":"crossref","unstructured":"Kitano Y, Kuwabara S, Misawa S, Ogawara K, Kanai K, Kikkawa Y, et al. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol2004; 56: 462\u20137.","DOI":"10.1002\/ana.20232"},{"key":"key\n\t\t\t\t20171011181925_B30","doi-asserted-by":"crossref","unstructured":"Koh D-S, Jonas P, Br\u00e4u M, Vogel W. A TEA-insensitive flickering potassium channel active around the resting potential in myelinated nerve. J Membr Biol1992; 130: 149\u201362.","DOI":"10.1007\/BF00231893"},{"key":"key\n\t\t\t\t20171011181925_B31","doi-asserted-by":"crossref","unstructured":"Koh D-S, Jonas P, Vogel W. Na+-activated K+ channels localized in the nodal region of myelinated axons of Xenopus. J Physiol1994; 479: 183\u201397.","DOI":"10.1113\/jphysiol.1994.sp020287"},{"key":"key\n\t\t\t\t20171011181925_B32","doi-asserted-by":"crossref","unstructured":"Kriz J, Gowing G, Julien JP. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol2003; 53: 429\u201336.","DOI":"10.1002\/ana.10500"},{"key":"key\n\t\t\t\t20171011181925_B33","doi-asserted-by":"crossref","unstructured":"Kuo JJ, Siddique T, Fu R, Heckman CJ. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol2005; 563: 843\u201354.","DOI":"10.1113\/jphysiol.2004.074138"},{"key":"key\n\t\t\t\t20171011181925_B34","doi-asserted-by":"crossref","unstructured":"Kuwabara S, Cappelen-Smith C, Lin CS, Mogyoros I, Burke D. Excitability properties of median and peroneal motor axons. Muscle Nerve2000; 23: 1365\u201373.","DOI":"10.1002\/1097-4598(200009)23:9<1365::AID-MUS7>3.0.CO;2-1"},{"key":"key\n\t\t\t\t20171011181925_B35","doi-asserted-by":"crossref","unstructured":"Kuwabara S, Ogawara K, Sung J-Y, Mori M, Kannai K, Hattori T, et al. Differences in membrane properties of axonal and demyelinating Guillain-Barre syndromes. Ann Neurol2002; 52: 180\u20137.","DOI":"10.1002\/ana.10275"},{"key":"key\n\t\t\t\t20171011181925_B36","doi-asserted-by":"crossref","unstructured":"Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II. Lancet1996; 347: 1425\u201331.","DOI":"10.1016\/S0140-6736(96)91680-3"},{"key":"key\n\t\t\t\t20171011181925_B37","doi-asserted-by":"crossref","unstructured":"LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascano J, Tokito M, et al. Disruption of dynein\/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron2002; 34: 715\u201327.","DOI":"10.1016\/S0896-6273(02)00696-7"},{"key":"key\n\t\t\t\t20171011181925_B38","doi-asserted-by":"crossref","unstructured":"Layzer RB. The origin of muscle fasciculations and cramps. Muscle Nerve1994; 17: 1243\u20139.","DOI":"10.1002\/mus.880171102"},{"key":"key\n\t\t\t\t20171011181925_B39","unstructured":"Liveson JA, Ma DM. Median nerve (motor). In: Liveson JA, Ma DM, editors, Laboratory reference for clinical neurophysiology. FA Davis: Philadelphia; 1992. p. 92\u201398."},{"key":"key\n\t\t\t\t20171011181925_B40","doi-asserted-by":"crossref","unstructured":"Mogyoros I, Kiernan M, Burke D, Bostock H. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain1998; 121: 851\u20139.","DOI":"10.1093\/brain\/121.5.851"},{"key":"key\n\t\t\t\t20171011181925_B41","doi-asserted-by":"crossref","unstructured":"Morrison KE. Therapies in amyotrophic lateral sclerosis beyond riluzole. Curr Opin Pharmacol2002; 2: 302\u20139.","DOI":"10.1016\/S1471-4892(02)00169-8"},{"key":"key\n\t\t\t\t20171011181925_B42","unstructured":"Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical recipes in C\u2014the art of scientific computing. Cambridge: Cambridge University Press; 1992. p. 707\u201324."},{"key":"key\n\t\t\t\t20171011181925_B43","doi-asserted-by":"crossref","unstructured":"Rekling JC. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen\/glucose deprivation. Neurosci Lett2003; 335: 167\u201370.","DOI":"10.1016\/S0304-3940(02)01193-X"},{"key":"key\n\t\t\t\t20171011181925_B44","doi-asserted-by":"crossref","unstructured":"Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med2001; 344: 1688\u2013700.","DOI":"10.1056\/NEJM200105313442207"},{"key":"key\n\t\t\t\t20171011181925_B45","doi-asserted-by":"crossref","unstructured":"Schwarz JR, Reid G, Bostock H. Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch1995; 430: 283\u201392.","DOI":"10.1007\/BF00374660"},{"key":"key\n\t\t\t\t20171011181925_B46","doi-asserted-by":"crossref","unstructured":"Urbani A, Belluzzi O. Riluzole inhibits persistent sodium current in mammalian CNS neurons. Eur J Neurosci2000; 12: 3567\u201374.","DOI":"10.1046\/j.1460-9568.2000.00242.x"},{"key":"key\n\t\t\t\t20171011181925_B47","doi-asserted-by":"crossref","unstructured":"Wang H, Zhang YL, Tang XC, Feng HS, Hu G. Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain. Mol Pharmacol2004; 66: 1160\u20138.","DOI":"10.1124\/mol.104.003178"},{"key":"key\n\t\t\t\t20171011181925_B48","doi-asserted-by":"crossref","unstructured":"Wickenden AD. Potassium channels as anti-epileptic drug targets. Neuropharmacology2002; 43: 1055\u201360.","DOI":"10.1016\/S0028-3908(02)00237-X"},{"key":"key\n\t\t\t\t20171011181925_B49","doi-asserted-by":"crossref","unstructured":"Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem2002; 80: 616\u201325.","DOI":"10.1046\/j.0022-3042.2001.00731.x"},{"key":"key\n\t\t\t\t20171011181925_B50","doi-asserted-by":"crossref","unstructured":"World Federation of Neurology Research Group on Neuromuscular Disease. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci1994; 124 (Suppl.): 96\u2013107.","DOI":"10.1016\/0022-510X(94)90191-0"},{"key":"key\n\t\t\t\t20171011181925_B51","doi-asserted-by":"crossref","unstructured":"Xu L, Enyeart JA, Enyeart JJ. Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism. J Pharmacol Exp Ther2001; 299: 227\u201337.","DOI":"10.1016\/S0022-3565(24)29322-8"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/129\/4\/953\/1056378\/awl024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T17:59:34Z","timestamp":1736272774000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/brain\/article\/129\/4\/953\/371207\/Altered-axonal-excitability-properties-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,8]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,2,8]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awl024","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2006,2,8]]}}}